Table 1 Baseline characteristics of males and females with and without hypertriglyceridemia (HTG)

Male

N

63

70

–

Age, y

31.65 ± 9.63

31.94 ± 7.77

0.847

SP, mmHg

132 ± 16.08

126.26 ± 10.6

0.215

BP, mmHg

81.38 ± 7.46

83.16 ± 7.2

0.478

BMI, kg/m2

44.85 ± 8.84

41.92 ± 7.13

0.036

WC, cm

129.91 ± 15.02

126 ± 15.34

0.164

FBG, mmol/L

5.98 ± 1.33

7.4 ± 3.82

0.004

FINS, uIU/mL

34.98 ± 21.35

38.26 ± 23.44

0.417

C-Peptide, ng/mL

4.63 ± 1.49

5.23 ± 1.83

0.048

TC, mmol/L

4.63 ± 0.8

5.43 ± 1.02

 < 0.001

TG, mmol/L

1.24 ± 0.26

3.93 ± 4.16

 < 0.001

HDL-C, mmol/L

0.97 ± 0.15

0.98 ± 0.18

0.709

LDL-C, mmol/L

3.14 ± 0.65

3.37 ± 0.75

0.06

ApoC3, mg/dL

7.03 ± 1.58

15.77 ± 8.75

 < 0.001

ApoC2, mg/dL

2.75 ± 0.92

5.19 ± 1.48

 < 0.001

TT, nmol/L

8.97 ± 4.17

8.9 ± 2.97

0.563

E2, pmol/L

198.94 ± 86.53

180.18 ± 63.92

0.249

PRG, ng/mL

0.60 (0.44, 0.89)

0.61 (0.46, 0.78)

0.924

OC, ug/L

20.01 ± 6.68

22.27 ± 7.73

0.185

Female

N

128

158

–

Age, y

32.25 ± 8.23

33.04 ± 7.74

0.346

SBP, mmHg

127.57 ± 13.88

130.2 ± 16.21

0.309

DBP, mmHg

82.57 ± 10.25

84.91 ± 11.5

0.212

BMI, kg/m2

38.08 ± 6.25

38 ± 6.2

0.907

WC, cm

111.17 ± 14.65

112.56 ± 13.56

0.371

FBG, mmol/L

5.68 ± 1.31

6.83 ± 2.79

 < 0.001

FINS, uIU/mL

27.16 ± 16.35

30.41 ± 16.22

0.061

C-Peptide, ng/mL

3.84 ± 1.23

4.38 ± 1.43

 < 0.001

TC, mmol/L

4.6 ± 0.74

5.12 ± 0.87

 < 0.001

TG, mmol/L

1.23 ± 0.3

2.58 ± 1.29

 < 0.001

HDL-C, mmol/L

1.16 ± 0.29

1.04 ± 0.19

 < 0.001

LDL-C, mmol/L

2.95 ± 0.56

3.29 ± 0.67

 < 0.001

ApoC3, mg/dL

8.09 ± 2.05

13.05 ± 4.37

 < 0.001

ApoC2, mg/dL

3.04 ± 0.94

4.94 ± 1.75

 < 0.001

TT, nmol/L

2.1 ± 0.95

1.99 ± 0.97

0.157

E2, pmol/L

345.4 ± 263.14

303.82 ± 294.21

0.047

PRG, ng/mL

0.79 (0.57, 9.39)

0.71 (0.47, 1.40)

0.171

OC, ug/L

21.08 ± 7.39

20.45 ± 8.68

0.299